West Announces Leadership Changes

Executive Leadership Changes - Bernard J. Birkett has announced his intention to retire from his position as Chief Financial Officer (CFO) of West Pharmaceutical Services, Inc. The company has initiated a search for his successor [2][7] - Birkett has been with West since June 2018 and has played a critical role in navigating challenges such as the global pandemic and the emergence of GLP-1s [2][3] - Shane Campbell has been appointed as Senior Vice President, Chief Proprietary Segment Officer, effective May 5, 2025. He brings extensive global management experience from his previous roles [3][4] Company Performance - West Pharmaceutical Services generated $2.89 billion in net sales in its fiscal year 2024, indicating strong financial performance [10] - The company is recognized as a leader in providing innovative, high-quality injectable solutions and services, supporting the delivery of life-saving medicines [9][10] Future Outlook - The company is focused on continuing its growth and success through its Proprietary Products strategy, leveraging the experience of new leadership [4][5]